Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia

NCT06791122 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT06791122
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06791122 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Pragmatic Study to Evaluate Clinical Effectiveness, Engagement With the Study App, Healthcare Resource Utilization, and Safety of an Investigational Digital Therapeutic (CT-155) in Patients With Experiential Negative Symptoms of Schizophrenia
Lead sponsor
Boehringer Ingelheim
Phase
Not applicable
Overall status
Completed
Start date
January 23, 2025
Completion date
August 24, 2026
Enrollment
262 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia